SLE ( Systemic Lupus Erythematosus )

Systemic Lupus Erythematosus ( SLE ) is the most common form of lupus. Widespread inflammation and tissue damage of joints, skin, brain, lungs, kidneys, and blood vessels occur due to the immune system attacking its own healthy tissues. Below are COVID news and research updates that specifically relate to SLE.

COVID-19 Vaccine Tolerance in Patients with Rheumatoid Arthritis

Researchers created an online questionnaire for RA and AIRD patients to self-report short-term COVID-19 vaccine-related adverse events. Vaccines included in the study were Pfizer, Moderna, Johnson & Johnson, AstraZeneca, Covaxin, and Sinopharm. The most common coexisting autoimmune diseases were thyroid disorders, systemic lupus erythematosus (SLE) and Sjogren’s syndrome (10.0%, 2.6%, and 2.5%, respectively).

Read More »

Occurrence of Autoimmune Diseases following COVID-19

COVID-19 and autoimmune disease share some similarities regarding molecular mechanisms of diseases. The authors of a paper published in November 2022 suggest that drugs used to treat autoimmune patients can serve as a potential treatment for COVID-19 patients.

Read More »

Long COVID & Systemic Autoimmune Rheumatic Diseases

Those suffering from systemic autoimmune rheumatic diseases have an increased risk of severe outcomes from a COVID-19 infection. Due to factors such as altered immunity or the use of immunosuppressive medications, they may also be at risk of developing Long COVID.

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.